期刊
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
卷 57, 期 19, 页码 5257-5261出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.201711825
关键词
Cdk2; covalent inhibition; fragment-based drug discovery; kinetics; protein modification
资金
- Institute of Chemical Biology (Imperial College London)
- UK Engineering and Physical Sciences Research Council [EP/F500416/1]
- Biotechnology and Biological Sciences Research Council [BB/J014575/1]
- Cancer and Polio Research Fund
Cysteine-reactive small molecules are used as chemical probes of biological systems and as medicines. Identifying high-quality covalent ligands requires comprehensive kinetic analysis to distinguish selective binders from pan-reactive compounds. Quantitative irreversible tethering (qIT), a general method for screening cysteine-reactive small molecules based upon the maximization of kinetic selectivity, is described. This method was applied prospectively to discover covalent fragments that target the clinically important cell cycle regulator Cdk2. Crystal structures of the inhibitor complexes validate the approach and guide further optimization. The power of this technique is highlighted by the identification of a Cdk2-selective allosteric (type IV) kinase inhibitor whose novel mode-of-action could be exploited therapeutically.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据